The above-mentioned data suggest that FGF1 treatment ameliorated hyperglycemia and subsequently oxidative stress during diabetes-induced liver injury via regulation of the FGFR1-AMPK-Nrf2/HO-1 signaling pathway. This evidence concerns the gene FGF1 and Hyperglycemia.